2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

30 trials found

diseases per page:

Showing 1 to 10 of 30 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05568615 (ClinicalTrials.gov)	October 26, 2022	2/10/2022	Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravonein ...	Multicenter, Open-label Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Saf ...	ALS	Drug: MT-1186	Mitsubishi Tanabe Pharma Corporation	NULL	Recruiting	18 Years	N/A	All	30	Phase 3	Japan
2	EUCTR2021-003900-42-DE (EUCTR)	15/07/2022	17/03/2022	Continued Efficacy and Safety Study of Oral EdaravoneFollowing Study MT-1186-A02 in Subjects with Am ...	A Phase 3b, Multicenter, Randomized, Double-blind Extension Study to Evaluate the Continued Efficacy ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 21.1;Level: PT;Classification code 10002026;Term ...	Product Name: Edaravone Product Code: MT-1186 INN or Proposed INN: EDARAVONE	Mitsubishi Tanabe Pharma Development America, Inc. (MTDA)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	United States;Canada;Germany;Italy;Switzerland;Japan;Korea, Republic of
3	EUCTR2020-003376-40-SE (EUCTR)	23/02/2022	29/12/2021	A study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclero ...	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	Amyotrophic Lateral Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyo ...	Product Name: Edaravone Product Code: FAB122 INN or Proposed INN: EDARAVONE	Ferrer Internacional, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	France;Portugal;Spain;Poland;Belgium;Ireland;Russian Federation;Netherlands;Germany;United Kingdom;I ...
4	JPRN-jRCT2071210117	23/02/2022	21/01/2022	Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS	A Phase 3b, Multicenter, Randomized, Double-blind Extension Study to Evaluate the Continued Efficacy ...	Amyotrophic Lateral Sclerosis	- Oral edaravoneadministered once daily for up to 48 weeks or until the drug is commercially availab ...	Kondo Kazuoki	NULL	Recruiting	>= 18age old	Not applicable	Both	300	Phase 3	US;Canada;Germany;Italia;South Korea;Switzerland;Japan
5	NCT05151471 (ClinicalTrials.gov)	January 11, 2022	28/11/2021	Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS	A Phase 3b, Multicenter, Randomized, Double-blind Extension Study to Evaluate the Continued Efficacy ...	ALS	Drug: MT-1186;Drug: Placebo	Mitsubishi Tanabe Pharma Development America, Inc.	NULL	Recruiting	18 Years	N/A	All	300	Phase 3	United States;Canada;Germany;Japan;Korea, Republic of;Switzerland;United Kingdom
6	EUCTR2020-003376-40-DE (EUCTR)	26/10/2021	16/06/2021	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 21.1;Level: PT;Classification code 10002026;Term ...	Product Name: Edaravone Product Code: FAB122 INN or Proposed INN: EDARAVONE	Ferrer Internacional, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	France;Portugal;Spain;Poland;Belgium;Ireland;Russian Federation;Netherlands;Germany;United Kingdom;I ...
7	NCT05178810 (ClinicalTrials.gov)	October 18, 2021	16/12/2021	Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyot ...	A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Sa ...	Amyotrophic Lateral Sclerosis	Drug: FAB122;Drug: Placebo	Ferrer Internacional S.A.	Julius Clinical;Stichting TRICALS Foundation	Active, not recruiting	18 Years	80 Years	All	300	Phase 3	Belgium;France;Germany;Ireland;Italy;Netherlands;Poland;Portugal;Spain;Sweden;United Kingdom
8	EUCTR2020-003376-40-IE (EUCTR)	12/10/2021	10/06/2021	A study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclero ...	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	Amyotrophic Lateral Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyo ...	Product Name: Edaravone Product Code: FAB122	Ferrer Internacional, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	Portugal;France;Spain;Poland;Belgium;Ireland;Russian Federation;Netherlands;Germany;United Kingdom;I ...
9	EUCTR2020-003376-40-ES (EUCTR)	05/10/2021	23/06/2021	A study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclero ...	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	Amyotrophic Lateral Sclerosis MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyo ...	Product Name: Edaravone Product Code: FAB122 INN or Proposed INN: EDARAVONE	Ferrer Internacional, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	France;Poland;Belgium;Spain;Ireland;Russian Federation;Netherlands;Germany;United Kingdom;Italy
10	EUCTR2020-003376-40-IT (EUCTR)	28/09/2021	19/10/2021	A study to investigate the efficacy and safety of FAB122 in patients with Amyotrophic Lateral Sclero ...	A multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and sa ...	Amyotrophic Lateral Sclerosis;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: Edaravone Product Code: [FAB122] INN or Proposed INN: Edaravone Other descriptive name: N ...	Ferrer Internacional S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	300	Phase 3	France;Spain;Poland;Belgium;Ireland;Russian Federation;Netherlands;Germany;United Kingdom;Italy;Swed ...

First Previous1 2 3Next Last